BIOMAT Database Logo BIOMAT Database Logo

Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitors. 2008

Stephen T Wrobleski, and Shuqun Lin, and John Hynes, and Hong Wu, and Sidney Pitt, and Ding Ren Shen, and Rosemary Zhang, and Kathleen M Gillooly, and David J Shuster, and Kim W McIntyre, and Arthur M Doweyko, and Kevin F Kish, and Jeffrey A Tredup, and Gerald J Duke, and John S Sack, and Murray McKinnon, and John Dodd, and Joel C Barrish, and Gary L Schieven, and Katerina Leftheris
Department of Immunology Chemistry, Bristol-Myers Squibb, Princeton, NJ 08543-4000, USA. stephen.wrobleski@bms.com

A novel series of compounds based on the pyrrolo[2,1-f][1,2,4]triazine ring system have been identified as potent p38 alpha MAP kinase inhibitors. The synthesis, structure-activity relationships (SAR), and in vivo activity of selected analogs from this class of inhibitors are reported. Additional studies based on X-ray co-crystallography have revealed that one of the potent inhibitors from this series binds to the DFG-out conformation of the p38 alpha enzyme.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D005260 Female Females
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014227 Triazines Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES. Triazine,Benzotriazines
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Stephen T Wrobleski, and Shuqun Lin, and John Hynes, and Hong Wu, and Sidney Pitt, and Ding Ren Shen, and Rosemary Zhang, and Kathleen M Gillooly, and David J Shuster, and Kim W McIntyre, and Arthur M Doweyko, and Kevin F Kish, and Jeffrey A Tredup, and Gerald J Duke, and John S Sack, and Murray McKinnon, and John Dodd, and Joel C Barrish, and Gary L Schieven, and Katerina Leftheris
Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors.
August 2011, Bioorganic & medicinal chemistry letters,
Stephen T Wrobleski, and Shuqun Lin, and John Hynes, and Hong Wu, and Sidney Pitt, and Ding Ren Shen, and Rosemary Zhang, and Kathleen M Gillooly, and David J Shuster, and Kim W McIntyre, and Arthur M Doweyko, and Kevin F Kish, and Jeffrey A Tredup, and Gerald J Duke, and John S Sack, and Murray McKinnon, and John Dodd, and Joel C Barrish, and Gary L Schieven, and Katerina Leftheris
Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitors.
September 2016, Bioorganic & medicinal chemistry letters,
Stephen T Wrobleski, and Shuqun Lin, and John Hynes, and Hong Wu, and Sidney Pitt, and Ding Ren Shen, and Rosemary Zhang, and Kathleen M Gillooly, and David J Shuster, and Kim W McIntyre, and Arthur M Doweyko, and Kevin F Kish, and Jeffrey A Tredup, and Gerald J Duke, and John S Sack, and Murray McKinnon, and John Dodd, and Joel C Barrish, and Gary L Schieven, and Katerina Leftheris
Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors.
March 2005, Bioorganic & medicinal chemistry letters,
Stephen T Wrobleski, and Shuqun Lin, and John Hynes, and Hong Wu, and Sidney Pitt, and Ding Ren Shen, and Rosemary Zhang, and Kathleen M Gillooly, and David J Shuster, and Kim W McIntyre, and Arthur M Doweyko, and Kevin F Kish, and Jeffrey A Tredup, and Gerald J Duke, and John S Sack, and Murray McKinnon, and John Dodd, and Joel C Barrish, and Gary L Schieven, and Katerina Leftheris
Discovery and process synthesis of novel 2,7-pyrrolo[2,1-f][1,2,4]triazines.
August 2011, Organic letters,
Stephen T Wrobleski, and Shuqun Lin, and John Hynes, and Hong Wu, and Sidney Pitt, and Ding Ren Shen, and Rosemary Zhang, and Kathleen M Gillooly, and David J Shuster, and Kim W McIntyre, and Arthur M Doweyko, and Kevin F Kish, and Jeffrey A Tredup, and Gerald J Duke, and John S Sack, and Murray McKinnon, and John Dodd, and Joel C Barrish, and Gary L Schieven, and Katerina Leftheris
Synthesis, SAR, and Evaluation of 4-[2,4-Difluoro-5-(cyclopropylcarbamoyl)phenylamino]pyrrolo[2,1-f][1,2,4]triazine-based VEGFR-2 kinase inhibitors.
February 2008, Bioorganic & medicinal chemistry letters,
Stephen T Wrobleski, and Shuqun Lin, and John Hynes, and Hong Wu, and Sidney Pitt, and Ding Ren Shen, and Rosemary Zhang, and Kathleen M Gillooly, and David J Shuster, and Kim W McIntyre, and Arthur M Doweyko, and Kevin F Kish, and Jeffrey A Tredup, and Gerald J Duke, and John S Sack, and Murray McKinnon, and John Dodd, and Joel C Barrish, and Gary L Schieven, and Katerina Leftheris
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinase.
March 2008, Bioorganic & medicinal chemistry letters,
Stephen T Wrobleski, and Shuqun Lin, and John Hynes, and Hong Wu, and Sidney Pitt, and Ding Ren Shen, and Rosemary Zhang, and Kathleen M Gillooly, and David J Shuster, and Kim W McIntyre, and Arthur M Doweyko, and Kevin F Kish, and Jeffrey A Tredup, and Gerald J Duke, and John S Sack, and Murray McKinnon, and John Dodd, and Joel C Barrish, and Gary L Schieven, and Katerina Leftheris
2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: modification of target structure to minimize reactive metabolite formation.
December 2011, Bioorganic & medicinal chemistry letters,
Stephen T Wrobleski, and Shuqun Lin, and John Hynes, and Hong Wu, and Sidney Pitt, and Ding Ren Shen, and Rosemary Zhang, and Kathleen M Gillooly, and David J Shuster, and Kim W McIntyre, and Arthur M Doweyko, and Kevin F Kish, and Jeffrey A Tredup, and Gerald J Duke, and John S Sack, and Murray McKinnon, and John Dodd, and Joel C Barrish, and Gary L Schieven, and Katerina Leftheris
Synthesis of 3-(carboxyarylalkyl)imidazo[2,1-f][1,2,4]triazines as potential inhibitors of AMP deaminase.
December 2008, Organic & biomolecular chemistry,
Stephen T Wrobleski, and Shuqun Lin, and John Hynes, and Hong Wu, and Sidney Pitt, and Ding Ren Shen, and Rosemary Zhang, and Kathleen M Gillooly, and David J Shuster, and Kim W McIntyre, and Arthur M Doweyko, and Kevin F Kish, and Jeffrey A Tredup, and Gerald J Duke, and John S Sack, and Murray McKinnon, and John Dodd, and Joel C Barrish, and Gary L Schieven, and Katerina Leftheris
Pyrrolo[2,1-c][1,2,4]triazines from 2-diazopyrroles: synthesis and antiproliferative activity.
March 2002, European journal of medicinal chemistry,
Stephen T Wrobleski, and Shuqun Lin, and John Hynes, and Hong Wu, and Sidney Pitt, and Ding Ren Shen, and Rosemary Zhang, and Kathleen M Gillooly, and David J Shuster, and Kim W McIntyre, and Arthur M Doweyko, and Kevin F Kish, and Jeffrey A Tredup, and Gerald J Duke, and John S Sack, and Murray McKinnon, and John Dodd, and Joel C Barrish, and Gary L Schieven, and Katerina Leftheris
Synthesis and Biochemical Testing of 3-(Carboxyphenylethyl)imidazo[2,1-f][1,2,4]triazines as Inhibitors of AMP Deaminase.
September 2010, ACS medicinal chemistry letters,
Copied contents to your clipboard!